Department of Chemistry, Faculty of Science, University of Guilan, Rasht, Iran.
Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mol Divers. 2023 Oct;27(5):2345-2352. doi: 10.1007/s11030-022-10560-z. Epub 2023 Feb 8.
This paper describes the development of 4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxylate compound as a heterocyclic enols containing a Michael acceptor so that it participates in an Ugi-type multicomponent condensation through a Smiles rearrangement in replacement of acid components. The new four-component containing 4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxylate, aldehyde derivatives, amine derivatives and isocyanides process leads readily and efficiently to heterocyclic enamines. This report is an outstanding strategy for the preparation of new biologically structures containing peptidic or pseudo-peptidic with quinolin-2(1H)-one scaffolds.
本文介绍了 4-羟基-2-氧代-1,2-二氢喹啉-3-羧酸酯化合物的开发,该化合物是一种含有迈克尔受体的杂环烯醇,可通过 Smiles 重排替代酸性成分,参与 Ugi 型多组分缩合反应。新的四组分反应体系含有 4-羟基-2-氧代-1,2-二氢喹啉-3-羧酸酯、醛衍生物、胺衍生物和异氰化物,反应条件温和、高效,可得到杂环烯胺。本报告提供了一种制备含有肽或拟肽结构的新型生物活性分子的有效策略,这些分子具有喹啉-2(1H)-酮骨架。